AT-1 receptors mediate angiotensin-II induced stimulation of aldosterone release which is reported to be attributed to metabolic distortions associated to insulin resistance, including hyperglycemia, dyslipidemia and hypertension; events that are caused by acceleration of the atherosclerotic process and endothelial dysfunction [11]. The gene discussed is AGT; the disease is metabolic syndrome.